These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17965510)

  • 1. Improvement after thalidomide and dexamethasone treatment for advanced cardiac amyloidosis: a case report.
    Choi JS; Hwang EN; Kim YH; Jung Y; Kim HJ; Nam SH; Park JI
    Circ J; 2007 Nov; 71(11):1823-5. PubMed ID: 17965510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intriguing case of primary amyloidosis with cardiac involvement: symptomatic and echocardiographic improvement with thalidomide treatment.
    Oh IY; Kim HK; Kim YJ; Sohn DW; Park YB
    Int J Cardiol; 2006 Oct; 113(1):141-3. PubMed ID: 16325941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide.
    Palladini G; Russo P; Lavatelli F; Nuvolone M; Albertini R; Bosoni T; Perfetti V; Obici L; Perlini S; Moratti R; Merlini G
    Ann Hematol; 2009 Apr; 88(4):347-50. PubMed ID: 18779964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early improvement in cardiac function detected by tissue Doppler and strain imaging after melphalan-dexamethasone therapy in a 51-year old subject with severe cardiac amyloidosis.
    Ballo P; Motto A; Corsini F; Orlandini F; Mondillo S
    Int J Cardiol; 2008 Nov; 130(2):278-82. PubMed ID: 17719107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.
    Palladini G; Russo P; Foli A; Milani P; Lavatelli F; Obici L; Nuvolone M; Brugnatelli S; Invernizzi R; Merlini G
    Ann Hematol; 2012 Jan; 91(1):89-92. PubMed ID: 21533608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
    Mahmood S; Venner CP; Sachchithanantham S; Lane T; Rannigan L; Foard D; Pinney JH; Gibbs SD; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Br J Haematol; 2014 Sep; 166(6):842-8. PubMed ID: 24930361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma cell leukaemia].
    Rodriguez C; Pont JC; Gouin-Thibault I; Andrieu AG; Molina T; Le Tourneau A; Le Garff-Tavernier M; Siguret V; Chaibi P
    Ann Biol Clin (Paris); 2005; 63(5):535-9. PubMed ID: 16230292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac amyloidosis--sustained clinical and free light chain response to low dose thalidomide and corticosteroids.
    Campbell P; Murdock C
    Intern Med J; 2006 Feb; 36(2):137-9. PubMed ID: 16472271
    [No Abstract]   [Full Text] [Related]  

  • 9. Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma.
    Li Y; Hou J; Jiang H; Wang D; Fu W; Yuan Z; Chen Y; Zhou L
    Haematologica; 2007 Sep; 92(9):1246-9. PubMed ID: 17666363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of POEMS syndrome complicated by severe congestive heart failure with thalidomide.
    Inoue D; Kato A; Tabata S; Kitai T; Takiuchi Y; Kimura T; Shimoji S; Mori M; Nagai Y; Togami K; Matsushita A; Nagai K; Maruoka H; Imai Y; Beppu M; Kawamoto M; Takahashi T
    Intern Med; 2010; 49(5):461-6. PubMed ID: 20190484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone.
    Ramasamy K; Lim Z; Pagliuca A; Salisbury JR; Mufti GJ; Devereux S
    Haematologica; 2006 Aug; 91(8 Suppl):ECR44. PubMed ID: 16923528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Original case report of amyloidosis with pleural involvement: the role of echocardiography in the diagnosis].
    Roubille F; Billotet C; Roubille C
    Rev Med Interne; 2006 Oct; 27(10):794-6. PubMed ID: 16797793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 62-year-old man with wrist and hand pain.
    Setty AR; Robinson D
    Arthritis Rheum; 2009 Jan; 61(1):132-8. PubMed ID: 19116980
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma.
    Sviggum HP; Davis MD; Rajkumar SV; Dispenzieri A
    Arch Dermatol; 2006 Oct; 142(10):1298-302. PubMed ID: 17043184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.
    Kastritis E; Roussou M; Gavriatopoulou M; Migkou M; Kalapanida D; Pamboucas C; Kaldara E; Ntalianis A; Psimenou E; Toumanidis ST; Tasidou A; Terpos E; Dimopoulos MA
    Am J Hematol; 2015 Apr; 90(4):E60-5. PubMed ID: 25580702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis.
    Sanchorawala V; Finn KT; Fennessey S; Shelton A; Doros G; Zeldis JB; Seldin DC
    Blood; 2010 Sep; 116(11):1990-1. PubMed ID: 20847211
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematology: Is thalidomide combination a new option for myeloma?
    Palumbo A
    Nat Rev Clin Oncol; 2010 Aug; 7(8):425-6. PubMed ID: 20668477
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac amyloidosis: a treatable disease, often overlooked.
    Falk RH
    Circulation; 2011 Aug; 124(9):1079-85. PubMed ID: 21875922
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of AL amyloidosis in 2012; the benefit of new drugs (bortezomib, thalidomide, and lenalidomide). Summary of published clinical trials].
    Adam Z; Sčudla V; Krejčí M; Cermáková Z; Pour L; Král Z
    Vnitr Lek; 2013 Jan; 59(1):37-58. PubMed ID: 23428001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.